Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Enrolling by invitation × Cabergoline × Clear all

Phase

Status

Completed 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1

Interventions

sintilimab 1 Ropivacaine 1 Magnetic Resonance Spectroscopy 1 Gastrointestinal Microbiome 1 Fluorouracil 1 Eye Enucleation 1 Enoxaparin 1 Drug Therapy 1 Cryotherapy 1 Cabergoline 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

National Taiwan University Hospital

Phase 4 Enrolling by invitation

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡